Cancer Genetics Announces Distribution Partnership with Excilone

By Italia on June 10 2013

Cancer Genetics, Inc.’s (OTCQB: CGIX) (“CGI” or the “Company”) wholly-owned subsidiary, Cancer Genetics Italia, S.r.l. (“CGI Italia”), has entered into an agreement with Excilone (“Excilone”), based in Elancourt, France, for the distribution of CGI Italia’s oncology-focused fluorescence in situ hybridization (“FISH”) Probes. This new partnership expands CGI’s distribution network into the French, Belgian, and Swiss markets, representing […]

Continue Reading